前列腺多参数磁共振成像阴性可预测12针模板前列腺穿刺活检无临床显著前列腺癌
研究评估100例多参数磁共振成像(mpMRI)无可疑区域患者行12针模板穿刺活检的前列腺癌检出率,总体检出率27%(27/100),Gleason≥7仅3%(3/100),mpMRI阴性对Gleason≥7前列腺癌的阴性预测值为97%,结论认为mpMRI阴性者系统穿刺检出临床显著前列腺癌的概率约3%。
要点
- mpMRI阴性者12针系统穿刺总体前列腺癌检出率为27%(27/100)。
- mpMRI阴性者Gleason≥7前列腺癌检出率仅3%(3/100),阴性预测值97%。
- mpMRI阴性对全部前列腺癌的阴性预测值为73%。
核心结论
- mpMRI无可疑发现的患者行经直肠超声引导系统穿刺活检检出临床显著前列腺癌的概率约为3%。
- 该信息有助于指导mpMRI阴性时是否行系统经直肠超声引导穿刺活检的医患沟通。
研究设计与样本
- 2012年12月至2016年6月,670例患者接受mpMRI后行经直肠超声(TRUS)引导系统前列腺穿刺活检,其中100例mpMRI阴性者纳入分析。
- mpMRI序列包括T2加权成像、弥散加权成像和动态对比增强序列。
主要发现
- 100例患者平均年龄64.3岁,前列腺特异抗原7.2 ng/mL,前列腺体积71 mL。
- 总体前列腺癌检出率为27%(27/100)。
- 初诊穿刺患者检出率为26.3%(10/38),既往穿刺阴性者为12.1%(4/33),既往主动监测者为44.8%(13/29)。
- 总体Gleason≥7检出率为3%(3/100)。
- mpMRI阴性的阴性预测值对全部前列腺癌为73%,对Gleason≥7前列腺癌为97%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the negative predictive value of multiparametric magnetic resonance imaging (mpMRI), we evaluated the frequency of prostate cancer detection by 12-core template mapping biopsy in men whose mpMRI showed no suspicious regions. METHODS: Six hundred seventy patients underwent mpMRI followed by transrectal ultrasound (TRUS)-guided systematic prostate biopsy from December 2012 to June 2016. Of this cohort, 100 patients had a negative mpMRI. mpMRI imaging sequences included T2-weighted and diffusion-weighted imaging, and dynamic contrast enhancement sequences. RESULTS: The mean age, prostate-specific antigen, and prostate volume of the 100 men included were 64.3 years, 7.2 ng/mL, and 71 mL, respectively. Overall cancer detection was 27% (27 of 100). Prostate cancer was detected in 26.3% (10 of 38) of patients who were biopsy-naïve, 12.1% (4 of 33) of patients who had a prior negative biopsy, and in 44.8% (13 of 29) of patients previously on active surveillance; Gleason grade ≥7 was detected in 3% of patients overall (3 of 100). The negative predictive value of a negative mpMRI was 73% for all prostate cancer and 97% for Gleason ≥7 prostate cancer. CONCLUSION: There is an approximately 3% chance of detecting clinically significant prostate cancer with systematic TRUS-guided biopsy in patients with no suspicious findings on mpMRI. This information should help guide recommendations to patients about undergoing systematic TRUS-guided biopsy when mpMRI is negative.
引用
- Lu AJ, Syed JS, Nguyen KA, et al. Negative Multiparametric Magnetic Resonance Imaging of the Prostate Predicts Absence of Clinically Significant Prostate Cancer on 12-Core Template Prostate Biopsy. Urology. 2017. PMID: 28322902. doi:10.1016/j.urology.2017.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。